Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling

23 Oct 2014

Abstract excerpt

Exploring the molecular difference among breast cancer subtypes is of crucial importance in understanding its heterogeneity and seeking its effective clinical treatment. For this, several layers of information including immunohistochemical markers and a variety of high-throughput genomics approaches have been intensively used. Here we have explored the intrinsic differences among breast cancer subgroups defined...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogen and related hormone effects
Share to Gene expression and cancer classification
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25338681
DOI: 10.1038/srep06566

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profilingPMID 25338681Read ↗

Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity Read ↗

Combined Hormone Receptor and Human Epidermal Growth Factor Receptor-2 Expression Reflects Inter-and Intra-tumor Heterogeneity in Hormone Receptor-positive/human Epidermal Growth Factor Receptor-2-positive Breast CancerSemantic proximity Read ↗

Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerSemantic proximity Read ↗

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesSemantic proximity Read ↗

Integrated transcriptomic meta-analysis provides novel insights into breast cancer molecular subtypesSemantic proximity Read ↗

Multiomics insights on the onset, progression, and metastatic evolution of breast cancerSemantic proximity Read ↗

Hormone Receptor-status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic LandscapeSemantic proximity Read ↗

Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancerSemantic proximity Read ↗

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular SubtypesSemantic proximity Read ↗

Integrating multi-omics data reveals the characteristics of nitrogen metabolism-related genes in breast cancer and their potential value in prognosis prediction and immunotherapySemantic proximity Read ↗

Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving PathwaysSemantic proximity Read ↗

Deciphering HER2 Breast Cancer Disease: Biological and Clinical ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.